EMSTER KURT VON

CIK 00012525248 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001252524

Recent Transactions

50 trades

Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2025-07-03+7,500→ 7,500 total
Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2024-06-06+7,500→ 7,500 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−49,245→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−67,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−16,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−9,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−25,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−9,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−15,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−9,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Common Stock
2024-03-22−90,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−32,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−14,010→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−7,500→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−27,705→ 0 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2024-01-24+14,010→ 14,010 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-09-29−6,357→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Stock Appreciation Right
2023-09-29−3,372→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-09-29$5.00/sh+15,921→ 105,921 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-09-29−5,249→ 0 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-09-29$15.68/sh−15,921→ 90,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-09-29−943→ 0 total
Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2023-06-07+47,000→ 47,000 total
Sale
Jasper Therapeutics, Inc.$JSPR
Voting Common Stock
2023-04-13$1.49/sh−9,075→ 21,175 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2023-01-25+25,000→ 25,000 total
Award
Jasper Therapeutics, Inc.$JSPR
Voting Common Stock
2022-10-12+30,250→ 30,250 total
Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2022-03-21+78,045→ 78,045 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2022-01-25+67,000→ 67,000 total
Award
Vaxcyte, Inc.$PCVX
Stock option (right to buy)
2021-06-02+15,000→ 15,000 total
Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2021-05-18+2,187,504→ 2,187,504 total
Conversion
Vera Therapeutics, Inc.$VERA
Series C Preferred Stock
2021-05-18−2,187,504→ 0 total
Purchase
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2021-05-18$11.00/sh+772,727→ 2,960,231 total
Purchase
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2021-05-17$12.04/sh+17,828→ 17,828 total
Award
Vera Therapeutics, Inc.$VERA
Stock Option (right to buy)
2021-05-13+9,925→ 9,925 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2021-01-26+32,000→ 32,000 total
Conversion
Vaxcyte, Inc.$PCVX
Common Stock, $0.001 par value per share
2020-06-16+298,917→ 4,156,218 total
Conversion
Vaxcyte, Inc.$PCVX
Series C Preferred Stock
2020-06-16−454,812→ 0 total
Conversion
Vaxcyte, Inc.$PCVX
Series A Preferred Stock
2020-06-16−2,185,415→ 0 total
Conversion
Vaxcyte, Inc.$PCVX
Common Stock, $0.001 par value per share
2020-06-16+1,217,074→ 3,402,489 total
Conversion
Vaxcyte, Inc.$PCVX
Common Stock, $0.001 par value per share
2020-06-16+2,185,415→ 2,185,415 total
Conversion
Vaxcyte, Inc.$PCVX
Common Stock, $0.001 par value per share
2020-06-16+454,812→ 3,857,301 total
Conversion
Vaxcyte, Inc.$PCVX
Series D Preferred Stock
2020-06-16−298,917→ 0 total
Purchase
Vaxcyte, Inc.$PCVX
Common Stock, $0.001 par value per share
2020-06-16$16.00/sh+12,500→ 4,168,718 total
Conversion
Vaxcyte, Inc.$PCVX
Series B Preferred Stock
2020-06-16−1,217,074→ 0 total
Award
Vaxcyte, Inc.$PCVX
Stock option (right to buy)
2020-06-11+40,000→ 40,000 total
Award
Vaxcyte, Inc.$PCVX
Stock option (right to buy)
2020-06-11−40,000→ 40,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-15+49,245→ 49,245 total
Award
CymaBay Therapeutics, Inc.
Stock option (right to buy)
2019-01-29+27,705→ 27,705 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2018-12-18$29.70/sh−62,925→ 1,171,268 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2018-12-18$7.43/sh−53,492→ 131,036 total

Companies

Recent Filings

Address

C/O SOMAXON PHARMACEUTICALS, INC. 3830 VALLEY CENTRE DRIVE, SUITE 705-461

SAN DIEGO, CA, 92130

View on SEC.gov